OPTFSNA
SRPT icon

Old Point Trust & Financial Services N A’s Sarepta Therapeutics SRPT Stock Holding History

Old Point Trust & Financial Services N A’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$12.9K – 509
2024
Q1 		$12.9K Buy
+100
New +$12.3K ﹤0.01% 261

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Old Point Trust & Financial Services N A's SRPT Position: Q2 2024 in Review

Old Point Trust & Financial Services N A sold out of Sarepta Therapeutics (SRPT) in Q2 2024, closing a stake of 100 shares — an estimated $12.9K sold.

Old Point Trust & Financial Services N A first reported a position in SRPT in Q1 2024 and held it in 1 quarter. The position peaked at $12.9K in Q1 2024. 483 funds tracked by Wall St. Rank hold SRPT as of Q2 2024.

  • Old Point Trust & Financial Services N A reported no remaining Sarepta Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Old Point Trust & Financial Services N A sold 100 Sarepta Therapeutics shares in Q2 2024, an estimated $12.9K.
  • Old Point Trust & Financial Services N A first reported a position in Sarepta Therapeutics in Q1 2024 and held it in 1 quarter.
  • Old Point Trust & Financial Services N A's Sarepta Therapeutics position peaked at $12.9K in Q1 2024.
  • 483 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2024.

Based on Old Point Trust & Financial Services N A's 13F filing for Q2 2024, filed 13 Aug 2024.